+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Injectable Drug Delivery Devices Market- Product Image
Injectable Drug Delivery Devices Market- Product Image
New

Injectable Drug Delivery Devices Market

  • PDF Icon

    Report

  • 166 Pages
  • January 2025
  • Region: Global
  • BCC Research
  • ID: 6040169
Description Jump to:
The Injectable Drug Delivery Devices Market was valued at USD 216.5 billion in 2024, and is expected to reach USD 317.2 billion by 2029, rising at a CAGR of 7.90%.

Report Scope

This report covers the global market for injectable Drug Delivery Device. It provides market projections for 2029 and analyzes the injectable Drug Delivery Device market along the following parameters: product, usage type, route of administration, therapeutic application and end users. Based on product, the injectable Drug Delivery Device market is segmented into conventional devices and advanced injectable devices. Based on usage type, the market is segmented into disposable injectors and reusable injectors. Based on the route of administration, it is segmented into subcutaneous, intramuscular, intravenous and intradermal. Based on therapeutic application, the market is segmented into diabetes, oncology, autoimmune diseases and others. Based on end user, it is segmented into hospitals and clinics, home care settings and others. The report includes a detailed competitive landscape that covers major players, market share and recent strategic developments.

Additionally, the report breaks down market trends and growth prospects across different regions. It includes market forecasts, consumer insights and a thorough supply chain analysis. By addressing distribution channels, key suppliers and other such factors, the report aims to provide a comprehensive view of the market’s current state and future potential as this can help stakeholders make informed decisions and identify strategic opportunities in the injectable drug delivery device industry.

The report includes:

  • 46 data tables and 62 additional tables
  • Analyses of trends in the global market for injectable drug delivery devices, with market revenue data from 2021-2023, estimates for 2024 and projected CAGRs through 2029
  • Estimates of the market size and revenue growth prospects, along with a market share analysis by product, therapeutic area (application), route of administration, end user and region
  • Facts and figures pertaining to the market drivers, opportunities and challenges, emerging technologies and regulatory landscape
  • A Porter’s Five Forces model, and global supply chain and PESTLE analyses
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
  • Review of patents and patent applications filed on drug delivery release mechanisms and novel applications
  • A look at the pipeline drugs, clinical trial applications and potential markets for future developments
  • Analysis of the competitive landscape, including companies’ market shares, strategic alliances, M&A activities, and a venture funding outlook
  • Company profiles of major players within the industry, including BD, Sanofi, Ypsomed, Lilly, Gerresheimer AG, Medtronic, Pfizer Inc.

Table of Contents

Chapter 1 Executive Summary
  • Market Outlook
  • Scope of Report
  • Market Summary
Chapter 2 Market Overview
  • Overview
  • PESTEL Analysis
  • Porter’s Five Forces Analysis
  • Supply Chain Analysis
  • Raw Materials Sourcing
  • Manufacturing
  • Packaging and Labeling
  • Distribution and Logistics
  • Marketing, Sales, and End User
Chapter 3 Market Dynamics
  • Overview
  • Market Drivers
  • Increasing Prevalence of Chronic Diseases and Aging Population
  • Technological Advances
  • Patient Preference for Self-Administration
  • Advances in Biologics
  • Market Restraints
  • Safety Concerns
  • Market Opportunities
  • Emerging Markets
  • Market Challenges
  • Patient Compliance and Acceptance
Chapter 4 Regulatory Landscape
  • Overview
  • U.S.
  • EU
  • Japan
Chapter 5 Emerging Technologies and Developments
  • Emerging Technologies
  • 3D Printing
  • Nanoparticle Delivery Systems
  • Biodegradable and Sustained Release Systems
  • Patent Analysis
  • Patents by Year
  • Patents by Applicant
  • Patents by Owner
  • Patents by Inventor
  • Patents by Jurisdiction
  • Clinical Trials Analysis
  • Clinical Trials Analysis by Type of Study
  • Clinical Trials Analysis by Status
  • Clinical Trials Analysis by Phase
Chapter 6 Market Segmentation Analysis
  • Segmental Breakdown
  • Global Market for Injectable Drug Delivery Device
  • Market Analysis by Product
  • Conventional Injectable Devices
  • Advanced Injectable Devices
  • Market Breakdown by Usage Type
  • Disposable Injectors
  • Reusable Injectors
  • Market Breakdown by Route of Administration
  • Subcutaneous
  • Intramuscular
  • Intravenous
  • Intradermal
  • Market Breakdown by Therapeutic Application
  • Diabetes
  • Oncology
  • Autoimmune Diseases
  • Other Applications
  • Market Breakdown by End User
  • Hospital and Clinics
  • Homecare Settings
  • Others
  • Geographic Breakdown
  • Market Analysis by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
Chapter 7 Sustainability: An ESG Perspective in the Injectable Drug Delivery Device Industry
  • Overview
  • Understanding the ESG Data
  • Environmental Performance
  • Social Performance
  • Governance Performance
  • Concluding Remarks
Chapter 8 Competitive Intelligence
  • Overview
  • Strategies for Injectable Drug Delivery Device Manufacturers
  • Distribution Networks
Chapter 9 Appendix
  • Methodology
  • Company Profiles
  • Amgen Inc.
  • AstraZeneca
  • BD
  • Baxter
  • B. Braun SE
  • F. Hoffmann-La Roche Ltd.
  • Gerresheimer AG
  • Lilly
  • Merck & Co. Inc.
  • Medtronic
  • Pfizer Inc.
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.
  • Terumo Corp.
  • Ypsomed
  • Abbreviations
  • Sources
List of Tables
Summary Table: Global Market for Injectable Drug Delivery Device, Through 2029
Table 1: Diabetes by Region, 2021-2045
Table 2: Global Incidence of All Cancers, by WHO Region, 2022-2050
Table 3: Incidence of Cancer Cases, by Cancer Type, 2022
Table 4: Elderly Population, by Country, 2021 and 2022
Table 5: Regulatory Approval in the U.S. and Europe
Table 6: Patents Granted for Injectable Drug Delivery Device, by Applicant, 2021-2024*
Table 7: Patents Granted for Injectable Drug Delivery Device, by Owner, 2021-2024*
Table 8: Patents Granted for Injectable Drug Delivery Device, by Inventor, 2021-2024*
Table 9: Patents Granted for Injectable Drug Delivery Device, by Jurisdiction, 2021-2024*
Table 10: Clinical Trials in Injectable Drug Delivery Device, by Type of Study, Through November 2024
Table 11: Clinical Trials in Injectable Drug Delivery Device, by Status, Through October 2024
Table 12: Clinical Trials in Injectable Drug Delivery Device, by Phase, Through October 2024
Table 13: Global Market for Injectable Drug Delivery Device, Through 2029
Table 14: Global Market for Injectable Drug Delivery Device, by Product, Through 2029
Table 15: Global Market for Injectable Drug Delivery Device, by Usage Type, Through 2029
Table 16: Global Market for Injectable Drug Delivery Device, by Route of Administration, Through 2029
Table 17: Global Market for Injectable Drug Delivery Device, by Therapeutic Application, Through 2029
Table 18: Global Market for Injectable Drug Delivery Device, by End User, Through 2029
Table 19: Global Market for Injectable Drug Delivery Device, by Region, Through 2029
Table 20: North American Market for Injectable Drug Delivery Device, by Country, Through 2029
Table 21: North American Market for Injectable Drug Delivery Device, by Product, Through 2029
Table 22: North American Market for Injectable Drug Delivery Device, by Usage Type, Through 2029
Table 23: North American Market for Injectable Drug Delivery Device, by Route of Administration, Through 2029
Table 24: North American Market for Injectable Drug Delivery Device, by Therapeutic Application, Through 2029
Table 25: North American Market for Injectable Drug Delivery Device, by End User, Through 2029
Table 26: European Market for Injectable Drug Delivery Device, by Country, Through 2029
Table 27: European Market for Injectable Drug Delivery Device, by Product, Through 2029
Table 28: European Market for Injectable Drug Delivery Device, by Usage Type, Through 2029
Table 29: European Market for Injectable Drug Delivery Device, by Route of Administration, Through 2029
Table 30: European Market for Injectable Drug Delivery Device, by Therapeutic Application, Through 2029
Table 31: European Market for Injectable Drug Delivery Device, by End User, Through 2029
Table 32: Asia-Pacific Market for Injectable Drug Delivery Device, by Country, Through 2029
Table 33: Asia-Pacific Market for Injectable Drug Delivery Device, by Product, Through 2029
Table 34: Asia-Pacific Market for Injectable Drug Delivery Device, by Usage Type, Through 2029
Table 35: Asia-Pacific Market for Injectable Drug Delivery Device, by Route of Administration, Through 2029
Table 36: Asia-Pacific Market for Injectable Drug Delivery Device, by Therapeutic Application, Through 2029
Table 37: Asia-Pacific Market for Injectable Drug Delivery Device, by End User, Through 2029
Table 38: RoW Market for Injectable Drug Delivery Device, by Product, Through 2029
Table 39: RoW Market for Injectable Drug Delivery Device, by Usage Type, Through 2029
Table 40: RoW Market for Injectable Drug Delivery Device, by Route of Administration, Through 2029
Table 41: RoW Market for Injectable Drug Delivery Device, by Therapeutic Application, Through 2029
Table 42: RoW Market for Injectable Drug Delivery Device, by End User, Through 2029
Table 43: ESG Rankings for Major Injectable Drug Delivery Device Companies, 2024*
Table 44: ESG: Environmental Overview
Table 45: ESG: Social Performance Overview
Table 46: ESG: Governance Overview
Table 47: Injectable Drug Delivery Device Market: Leading Players
Table 48: Amgen Inc.: Company Snapshot
Table 49: Amgen Inc.: Financial Performance, FY 2022 and 2023
Table 50: Amgen Inc.: Product Portfolio
Table 51: Amgen Inc.: News/Key Developments, 2023
Table 52: AstraZeneca: Company Snapshot
Table 53: AstraZeneca: Financial Performance, FY 2022 and 2023
Table 54: AstraZeneca: Product Portfolio
Table 55: BD: Company Snapshot
Table 56: BD: Financial Performance, FY 2022 and 2023
Table 57: BD: Product Portfolio
Table 58: BD: News/Key Developments, 2022-2024
Table 59: Baxter: Company Snapshot
Table 60: Baxter: Financial Performance, FY 2022 and 2023
Table 61: Baxter: Product Portfolio
Table 62: Baxter: News/Key Developments, 2024
Table 63: B. Braun SE: Company Snapshot
Table 64: B. Braun SE: Financial Performance, FY 2022 and 2023
Table 65: B. Braun SE: Product Portfolio
Table 66: B. Braun SE: News/Key Developments, 2022-2024
Table 67: F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 68: F. Hoffmann-La Roche Ltd.: Financials, FY 2022 and 2023
Table 69: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 70: F. Hoffmann-La Roche Ltd.: News/Key Developments, 2022-2024
Table 71: Gerresheimer AG: Company Snapshot
Table 72: Gerresheimer AG: Financial Performance, FY 2022 and 2023
Table 73: Gerresheimer AG: Product Portfolio
Table 74: Gerresheimer AG: News/Key Developments, 2022-2024
Table 75: Lilly: Company Snapshot
Table 76: Lilly: Financial Performance, FY 2022 and 2023
Table 77: Lilly: Product Portfolio
Table 78: Lilly: News/Key Developments, 2022-2024
Table 79: Merck & Co. Inc.: Company Snapshot
Table 80: Merck & Co. Inc.: Financial Performance, FY 2022 and 2023
Table 81: Merck & Co. Inc.: Product Portfolio
Table 82: Merck & Co. Inc.: News/Key Developments, 2022 and 2023
Table 83: Medtronic: Company Snapshot
Table 84: Medtronic: Financial Performance, FY 2022 and 2023
Table 85: Medtronic: Product Portfolio
Table 86: Pfizer Inc.: Company Snapshot
Table 87: Pfizer Inc.: Financial Performance, FY 2022 and 2023
Table 88: Pfizer Inc.: Product Portfolio
Table 89: Pfizer Inc.: News/Key Developments, 2022
Table 90: Sanofi: Company Snapshot
Table 91: Sanofi: Financial Performance, FY 2022 and 2023
Table 92: Sanofi: Product Portfolio
Table 93: Sanofi: News/Key Developments, 2022-2024
Table 94: Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 95: Teva Pharmaceutical Industries Ltd.: Financial Performance, FY 2022 and 2023
Table 96: Teva Pharmaceutical Industries Ltd.: Product Portfolio
Table 97: Teva Pharmaceutical Industries Ltd.: News/Key Developments, 2024
Table 98: Terumo Corp.: Company Snapshot
Table 99: Terumo Corp.: Financial Performance, FY 2022 and 2023
Table 100: Terumo Corp.: Product Portfolio
Table 101: Terumo Corp.: News/Key Developments, 2022-2024
Table 102: Ypsomed: Company Snapshot
Table 103: Ypsomed: Financial Performance, FY 2022 and 2023
Table 104: Ypsomed: Product Portfolio
Table 105: Ypsomed: News/Key Developments, 2022-2024
Table 106: Abbreviations Used in This Report
Table 107: Report Sources
List of Figures
Summary Figure: Global Market for Injectable Drug Delivery Device, 2021-2029
Figure 1: Supply Chain Analysis of Injectable Drug Delivery Device Industry
Figure 2: Market Dynamics of Injectable Drug Delivery Devices
Figure 3: Emerging Technologies in the Injectable Drug Delivery Device Market
Figure 4: Patents Granted for Injectable Drug Delivery Device, by Year, 2021-2024*
Figure 5: Global Market Shares of Injectable Drug Delivery Device, by Product, 2023
Figure 6: Global Market Shares of Injectable Drug Delivery Device, by Usage Type, 2023
Figure 7: Global Market Shares of Injectable Drug Delivery Device, by Route of Administration, 2023
Figure 8: Global Market Shares of Injectable Drug Delivery Device, by Therapeutic Application, 2023
Figure 9: Global Market Shares of Injectable Drug Delivery Device, by End User, 2023
Figure 10: Global Market Shares of Injectable Drug Delivery Device, by Region, 2023
Figure 11: North American Market Shares of Injectable Drug Delivery Device, by Country, 2023
Figure 12: North American Market for Injectable Drug Delivery Device, 2021-2029
Figure 13: North American Market Shares of Injectable Drug Delivery Device, by Product, 2023
Figure 14: North American Market Shares of Injectable Drug Delivery Device, by Usage Type, 2023
Figure 15: North American Market Shares of Injectable Drug Delivery Device, by Route of Administration, 2023
Figure 16: North American Market Shares of Injectable Drug Delivery Device, by Therapeutic Application, 2023
Figure 17: North American Market Shares of Injectable Drug Delivery Device, by End User, 2023
Figure 18: European Market Shares of Injectable Drug Delivery Device, by Country, 2023
Figure 19: European Market for Injectable Drug Delivery Device, 2021-2029
Figure 20: European Market Shares of Injectable Drug Delivery Device, by Product, 2023
Figure 21: European Market Shares of Injectable Drug Delivery Device, by Usage Type, 2023
Figure 22: European Market Shares of Injectable Drug Delivery Device, by Route of Administration, 2023
Figure 23: European Market Shares of Injectable Drug Delivery Device, by Therapeutic Application, 2023
Figure 24: European Market Shares of Injectable Drug Delivery Device, by End User, 2023
Figure 25: Asia-Pacific Market Shares of Injectable Drug Delivery Device, by Country, 2023
Figure 26: Asia-Pacific Market for Injectable Drug Delivery Device, 2021-2029
Figure 27: Asia-Pacific Market Shares of Injectable Drug Delivery Device, by Product, 2023
Figure 28: Asia-Pacific Market Shares of Injectable Drug Delivery Device, by Usage Type, 2023
Figure 29: Asia-Pacific Market Shares of Injectable Drug Delivery Device, by Route of Administration, 2023
Figure 30: Asia-Pacific Market Shares of Injectable Drug Delivery Device, by Therapeutic Application, 2023
Figure 31: Asia-Pacific Market Shares of Injectable Drug Delivery Device, by End User, 2023
Figure 32: RoW Market for Injectable Drug Delivery Device, 2021-2029
Figure 33: RoW Market Shares of Injectable Drug Delivery Device, by Product, 2023
Figure 34: RoW Market Shares of Injectable Drug Delivery Device, by Usage Type, 2023
Figure 35: RoW Market Shares of Injectable Drug Delivery Device, by Route of Administration, 2023
Figure 36: RoW Market Shares of Injectable Drug Delivery Device, by Therapeutic Application, 2023
Figure 37: RoW Market Shares of Injectable Drug Delivery Device, by End User, 2023
Figure 38: ESG Metrics of Injectable Drug Delivery Device Companies
Figure 39: Amgen Inc.: Revenue Share, by Business Unit, FY 2023
Figure 40: Amgen Inc.: Revenue Share, by Country/Region, FY 2023
Figure 41: AstraZeneca: Revenue Share, by Business Unit, FY 2023
Figure 42: AstraZeneca: Revenue Share, by Region/Country, FY 2023
Figure 43: BD: Revenue Share, by Business Unit, FY 2023
Figure 44: BD: Revenue Share, by Country/Region, FY 2023
Figure 45: Baxter: Revenue Share, by Business Unit, FY 2023
Figure 46: Baxter: Revenue Share, by Country/Region, FY 2023
Figure 47: B. Braun SE: Revenue Share, by Business Unit, FY 2023
Figure 48: B. Braun SE: Revenue Share, by Country/Region, FY 2023
Figure 49: F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 50: F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 51: Gerresheimer AG: Revenue Share, by Business Unit, FY 2023
Figure 52: Gerresheimer AG: Revenue Share, by Country/Region, FY 2023
Figure 53: Lilly: Revenue Share, by Business Unit, FY 2023
Figure 54: Lilly: Revenue Share, by Region, FY 2023
Figure 55: Merck & Co. Inc.: Revenue Share, by Business Unit, FY 2023
Figure 56: Merck & Co. Inc.: Revenue Share, by Country/Region, FY 2023
Figure 57: Medtronic: Revenue Share, by Business Unit, FY 2023
Figure 58: Medtronic: Revenue Share, by Country/Region, FY 2023
Figure 59: Pfizer Inc.: Revenue Share, by Business Unit, 2023
Figure 60: Pfizer Inc.: Revenue Share, by Country/Region, 2023
Figure 61: Sanofi: Revenue Share, by Business Unit, FY 2023
Figure 62: Sanofi: Revenue Share, by Country/Region, FY 2023
Figure 63: Teva Pharmaceutical Industries Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 64: Teva Pharmaceutical Industries Ltd.: Revenue Share, by Country/Region, 2023
Figure 65: Terumo Corp.: Revenue Share, by Country/Region, FY 2023
Figure 66: Terumo Corp.: Revenue Share, by Business Unit, FY 2023
Figure 67: Ypsomed: Revenue Share, by Business Unit, FY 2023
Figure 68: Ypsomed: Revenue Share, by Country/Region, FY 2023

Companies Mentioned

  • Amgen Inc.
  • AstraZeneca
  • BD
  • Baxter
  • B. Braun SE
  • F. Hoffmann-La Roche Ltd.
  • Gerresheimer AG
  • Lilly
  • Merck & Co. Inc.
  • Medtronic
  • Pfizer Inc.
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.
  • Terumo Corp.
  • Ypsomed

Table Information

Report AttributeDetails
No. of Pages166
PublishedJanuary 2025
Forecast Period2024 - 2029
Estimated Market Value ( USD ) in 2024 $ 216.5 Billion
Forecasted Market Value ( USD ) by 2029 $ 317.2 Billion
Compound Annual Growth Rate7.9%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel, Patient Care Setting, & Region - Forecast to 2029 - Product Image

Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel, Patient Care Setting, & Region - Forecast to 2029

  • Report
  • 387 Pages
  • Global
From
Injectable Drug Delivery Devices Market Size, Share and Trends Analysis Report by Product (Devices, Formulations), Therapeutic Use (Autoimmune Disorders, Hormonal Disorders), End-use (Hospitals, Homecare Settings), and Region 2024-2030 - Product Image

Injectable Drug Delivery Devices Market Size, Share and Trends Analysis Report by Product (Devices, Formulations), Therapeutic Use (Autoimmune Disorders, Hormonal Disorders), End-use (Hospitals, Homecare Settings), and Region 2024-2030

  • Report
  • 100 Pages
  • Global
From
Injectable Drug Delivery Devices Global Market Report 2024 - Product Image

Injectable Drug Delivery Devices Global Market Report 2024

  • Report
  • 250 Pages
  • Global
From
Injectable Drug Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Injectable Drug Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 114 Pages
  • Global
From
Injectable Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Injectable Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.